Final results of the first-in-human study of the porcupine (PORCN) inhibitor zamaporvint (RXC004) in patients with advanced solid tumors

Natalie Cook, Sarah Blagden, Juanita Lopez, Debashis Sarker, Alastair Greystoke, Noor Md Haris, Farasat Kazmi, Kaiser Anam, Ana Ortego Franco, Rille Pihlak, Louise Goodwin, David Wilson, Caroline Phillips, Jane Robertson, Helen Timmis, Craig Tilston, Simon A. Woodcock, Ruth Plummer

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article numberCT101
Number of pages3
JournalCancer Research
Volume84
Issue number7 Supplement
DOIs
Publication statusPublished - 1 Apr 2024

Cite this